Nurse Practitioner, Family · Wylie, TX
NPI
1386293504
Since 2019
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1318 Iron Dale Dr
Wylie, TX, 75098
Phone (718) 415-5247
Groups this clinician bills Medicare through
Medicare paid, 2024
$105K
1,704 services
Medicare patients, 2024
151
Average age 67
Drug cost, 2024
$67K
201 prescriptions
Company payments, 2025
$1,669
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ugonna C Onwunali was code G0480 (drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms), 452 times for 119 patients. In total Ugonna C Onwunali billed 1,704 services in 21 codes, and Medicare paid $105K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-10.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 452 | 119 | $111.47 | $50K |
| 80307 Drug Tests | Office | 451 | 120 | $60.54 | $27K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 154 | 76 | $10.80 | $1,664 |
| 99214 Office E&M - Established | Office | 114 | 66 | $75.74 | $8,635 |
| 98980 Care Management/Coordination | Office | 95 | 29 | $33.43 | $3,176 |
| 98977 Pulmonary Function Testing | Office | 93 | 29 | $30.89 | $2,873 |
| 99213 Office E&M - Established | Office | 90 | 52 | $46.88 | $4,219 |
| 96138 Behavioral Health Services | Office | 78 | 51 | $22.59 | $1,762 |
| 98981 Care Management/Coordination | Office | 70 | 25 | $26.35 | $1,844 |
| 98975 Pulmonary | Office | 17 | 17 | $13.30 | $226 |
By year: 2022 $59K for 706 services; 2023 $71K for 1,142 services; 2024 $105K for 1,704 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 452 | 119 | $111.47 | $50K |
| 80307 Drug Tests | 451 | 120 | $60.54 | $27K |
Medicare prescription drug claims, 2024
In 2024, the drug Ugonna C Onwunali prescribed most often to Medicare patients was Piroxicam, with 70 prescriptions and refills. In total Ugonna C Onwunali wrote 201 Medicare prescriptions that cost $67K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Piroxicam Generic | 70 | 70 | 29 | $35K |
| Calcipotriene Generic | 60 | 82 | 23 | $24K |
| Celecoxib Generic | 11 | 15 | Under 11 | $172 |
Brand drugs: 12 claims; generic drugs: 189 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ugonna C Onwunali $1,669 ($1,669 in general payments such as food, travel and fees) from 17 companies. The largest payer was Forte Bio-Pharma LLC with $508.
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 37 | $508 |
| Spinal Simplicity, LLC | 7 | $191 |
| Bioventus LLC BVS | 8 | $186 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 8 | $156 |
| Pfizer Inc. PFE | 6 | $156 |
| Vertex Pharmaceuticals Incorporated VRTX | 5 | $103 |
| Curonix LLC | 1 | $69.81 |
| Scilex Pharmaceuticals Inc. | 4 | $63.57 |
| Averitas Pharma Inc. | 2 | $47.6 |
| SPR Therapeutics, Inc | 2 | $37.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.